Correlation of Growth of Aerobic Blood Cultures in Hypertonic Broth with Antibiotic Therapy
|
|
- Jessie Charles
- 6 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1982, p /82/ $02.00/0 Copyright 1982, American Society for Microbiology Vol. 16, No. 5 Correlation of Growth of Aerobic Blood Cultures in Hypertonic Broth with Antibiotic Therapy JAN ENG* AND ARILD MAELAND Microbiological Laboratory, Ullevdl Hospital, Oslo 1, Norway Received 22 April 1982/Accepted 28 July 1982 The aim of this study was to elucidate the mechanisms by which sucrose improves growth in a hypertonic medium for isolating aerobes from blood. Clinical blood cultures were made routinely in duplicate in plain broth consisting of brain heart infusion broth with sodium polyanetholesulfonate, gelatin, and penicillinase and the same broth with 20% sucrose added. The growth patterns of Staphylococcus aureus and Enterobacteriaceae from plain and from hypertonic broth were correlated with the presence or absence of antimicrobial therapy in patients when the blood cultures were collected. In S. aureus bacteremias, 58.7% of the positive cultures collected during treatment of patients with,b-lactam antibiotics showed earlier growth or growth only in hypertonic broth, compared with 16.7% of the cultures taken during treatment with other antimicrobial agents (P < 0.05) and 17.6% of the cultures made in antibiotic-free intervals (P < 0.01). In the group of cultures yielding growth of Enterobacteriaceae, growth occurred earlier or solely in hypertonic broth in 28.9% of the cultures taken during treatment with,b-lactam antibiotics, compared with 15.7% of the cultures taken during treatment with other antimicrobial agents and 21.6% of the cultures collected in antibiotic-free intervals (differences not statistically significant). It is concluded that treatment with 1-lactam antibiotics is an important reason for the improved growth of S. aureus from hypertonic broth, but other factors are also involved. In recent years, several workers have reported that the addition of 10 to 30% sucrose in broth media for clinical blood cultures enhances recoveries (3, 7, 9, 10, 16; L. R. McCarthy and P. D. Ellner, Abstr. Annu. Meet. Am. Soc. Microbiol. 1973, M48, p. 81), although negative findings have also been published (6, 18). The mechanisms by which sucrose seems to promote recoveries are, however, obscure. A leading hypothesis is that the sugar offers osmotic support to cell-wall-defective bacterial variants induced by 3-lactam antibiotics or immune substances (9, 14, 16). An inactivating effect of sucrose upon penicillins has also been reported (17). Theoretically, two possible mechanisms of growth improvement by sucrose in blood cultures from patients under treatment with 1- lactam antibiotics may thus be conceived. Thus, we found it of interest to determine the correlation between growth patterns in blood culture media with and without sucrose and the presence or absence of antimicrobial therapy in patients when the blood cultures were collected. Cultures yielding growth of Staphylococcus aureus or Enterobacteriaceae were selected for this study since we have found that the recoveries of these two groups of bacteria were significantly improved by adding 20% sucrose to the broth media used for clinical blood cultures in this laboratory (7). The blood cultures examined in the present study formed part of the material presented previously (7). MATERIALS AND METHODS All aerobic clinical blood cultures in this hospital were made in duplicate in plain (P) broth and hypertonic (H) broth media. Details of the techniques employed have been given previously (7). Briefly, P broth was made up of brain heart infusion broth with 0.05% sodium polyanetholesulfonate, 1.2% gelatin, and 20 IU of penicillinase per ml. Two types of H broth were in use at different times during the study: (i) P broth with 20o sucrose added and (ii) P broth with 20% sucrose and 0.1% magnesium sulfate. The two H broth media have been found to yield closely parallel results (7), and they are treated together in the present study. The penicillinase employed was Penase concentrate (Difco Laboratories, Detroit, Mich.) derived from Bacillus cereus. It is stated that 1 ml of the stock preparation inactivates 500,000 IU of penicillin as measured by a test described by the producer (5). The penicillinase was sterilized by filtration through a Millex-GS filter (Millipore Corp., Bedford, Mass.), diluted in sterile water, and added aseptically to the blood culture bottles in amounts calculated to inacti- 890
2 VOL. 16, 1982 ANTIBIOTICS AND GROWTH IN HYPERTONIC BROTH 891 TABLE 1. Growth patterns in P broth and H broth of 166 clinical blood cultures yielding growth of S. aureus Antibiotic treatment No. of cultures with growth pattern:0 Difference' of patients P > H P = H H > P No. of cultures % of totalc 1-Lactam < Other NSd None (antibiotic < free interval) P p > H, Growth occurred earlier in P broth or in P broth only; P = H, growth occurred simultaneously in both media; H > P, growth occurred earlier in H broth or in H broth only. b Number of (H > P) cultures minus number of (P > H) cultures. c For cultures from patients in all treatment groups, 28.9o (48 of 166). d NS, Not significant. vate 20 IU of penicillin per ml of the final medium. The actual capacities of the ready-made blood culture media to inactivate penicillin G were measured in several batches of P broth and H broth by a technique previously described (5). A 1-ml sample of broth was found to inactivate between 40 and 160 IU of penicillin G (after incubation of the reaction mixture for 2 h at room temperature) as measured in different experiments; no differences were observed between the two types of blood culture broth in their penicillinase activity. The measurements were repeated at intervals in batches of medium stored at 4 C, and the penicillinase activity was found to be fairly stable for at least 3 months. The media were distributed in 50-ml amounts to 100- ml glass bottles. The blood cultures were made by inoculating 5 ml of venous blood into each of the two bottles. The cultures were incubated unvented at 37 C for 4 days and were repeatedly subcultured onto chocolate agar plates (7). Five different growth patterns were recorded: growth simultaneously in both media, earlier growth (by 21 days) in P broth or in H broth, and growth in P broth or in H broth only. The bacterial strains isolated were identified by standard methods (4). Strains of S. aureus were tested for 1-lactamase production by the cloverleaf method (11). The clinical records of a consecutive series of 214 patients whose blood cultures yielded growth of S. aureus (60 patients) or Enterobacteriaceae (154 patients) were scrutinized in retrospect to map any antibiotic therapy given in relation to the time when blood cultures were collected. The patients with S. aureus bacteremia yielded 166 positive blood cultures, and those with enterobacterial bacteremia had a total of 342 positive blood cultures. The cultures were grouped according to whether they had been collected during antibiotic treatment or in antibiotic-free intervals. Different cultures from the same patient were in several instances placed in different treatment groups. Cultures in the treated group were subdivided on the basis of treatment with 13-lactam antibiotics and treatment with other antimicrobial agents. A culture was considered to be taken in an antibiotic-free interval if at least 3 days had elapsed since the last dose of an antimicrobial agent had been administered to the patient, but in most cultures in this group the antibioticfree interval was 1 week or more. In the treated group were included all cultures taken less than 24 h after the last dose of an antimicrobial agent. The statistical procedure used was the Fisher exact 2 x 2 test. RESULTS The growth patterns in P and H broths of cultures from the different treatment groups are shown in Table 1 (S. aureus cultures) and Table 2 (Enterobacteriaceae cultures). The two parameters of better growth in one or the other medium (earlier growth and growth in that medium only) are grouped together in the tables. It is seen from both tables that the number of cultures yielding earlier growth or growth only in H broth (H > P) significantly exceeded the corresponding number of cultures yielding the opposite growth pattern (P > H), both overall and in each subgroup of material (except for cultures with growth of S. aureus during treatment with other antimicrobial agents, which form too small a group for a statistical analysis). In addition, the difference between the number of cultures showing the growth pattern H > P and the corresponding number of cultures showing P > H was calculated as a percentage of the total number of cultures in the group concerned, and the resulting percentage was considered to represent a numerical index of the rate of growth improvement in H broth. The rate of growth improvement of S. aureus in H broth in blood cultures taken during treatment with,b-lactam antibiotics was 58.7%, whereas the corresponding rate in cultures taken in antibiotic-free intervals was 17.6% (Table 1). This difference is statistically significant (P < 0.01). Also, a comparison of the rates of growth improvement in H broth in the two groups of cultures collected during antimicrobial therapy (p-lactam antibiotics, 58.7%; other antimicrobial agents, 16.7%) (Table 1) shows a statistically significant difference (P < 0.05). For cultures yielding growth of Enterobacteriaceae (Table 2), the rate of growth im-
3 892 ENG AND MAELAND J. CLIN. MICROBIOL. TABLE 2. Growth patterns in P broth and H broth of 342 clinical blood cultures yielding growth of Enterobacteriaceae Antibotictreament No. of cultures with growth pattern: a Difference' of patients P > H P = H H > P No. of cultures % of total' f3-lactam < Other < None (antibiotic < free interval) a See Table 1, footnote a. b Number of (H > P) cultures minus number of (P > H) cultures. c For cultures from patients of all treatment groups, 22.5% (77 of 342). provement in H broth was 28.9% in cultures taken during treatment with P-lactam antibiotics, 15.7% in cultures taken during treatment with other antimicrobial agents, and 21.6% in cultures collected in antibiotic-free intervals. None of the differences between these rates of growth improvement in H broth is statistically significant. Table 3 presents further details on the 46 cultures from which S. aureus was isolated during treatment of the patients with P-lactam antibiotics. These cultures were collected from 17 patients altogether. The strains isolated from 12 of the patients were P-lactamase producers, and those from 5 patients were not. Eleven patients were under treatment with 13-lactam antibiotics sensitive to S. aureus 13-lactamase (penicillin G, penicillin V, or ampicillin), whereas six patients received 13-lactam antibiotics resistant to that enzyme (methicillin, cloxacillin, cephalothin, or cephalexin) either alone or in combination with penicillin G. The treatment regimens varied considerably, from oral treatment with regular doses to intensive parenteral antibiotic therapy. The growth patterns in P broth and H broth in each separate blood culture obtained from these patients are also shown. In 12 patients, S. aureus was isolated from blood cultures during treatment with other antimicrobial agents (Table 1), namely, doxycycline (5 patients), sulfonamides (2 patients), co-trimoxazole (4 patients), and nalidixic acid (1 patient). Of the 508 positive blood cultures examined altogether, 192 (37.8%) were collected while the patients were under antimicrobial treatment, the separate figures being 134 cultures (39.2%) yielding growth of Enterobacteriaceae and 58 cultures (34.9%) yielding growth of S. aureus. DISCUSSION The main findings of the present investigation were that the isolation of S. aureus from blood cultures was significantly improved in H broth both in cultures taken during antibiotic-free intervals and in cultures taken during treatment of the patients with P-lactam antibiotics; furthermore, growth was significantly more enhanced in the latter group of cultures (Tables 1 and 3). Also, Enterobacteriaceae (Table 2) grew better in H broth both in cultures collected during antibiotic-free intervals and in cultures collected during treatment with P-lactam antibiotics, but the rate of growth improvement did not differ significantly between the two groups. These findings are relevant to the following hypotheses for the mode of action of sucrose in blood culture media discussed in the literature. (i) Media supplemented with sucrose may possess nutritional advantages in the isolation of certain bacteria. This obvious possibility has, to our knowledge, been only slightly examined. Henrichsen and Bruun (10), however, who found that blood culture media containing 10% sucrose enhanced the growth of Enterobacteriaceae and S. aureus, found no correlation between the effect of sucrose on the isolation of Escherichia coi and the ability or inability of the strains to ferment sucrose. In this laboratory, H broth has been found to speed up the isolation of Salmonella species, which do not ferment sucrose. (The material published previously [7] comprised 70 blood cultures with growth of strains of Salmonella; of these, growth was detected earlier in H broth in 9 cases and earlier in P broth in 1 case [P < 0.02]). In the present study, the significant differences in the rates of growth promotion of S. aureus by sucrose between cultures taken during P-lactam antibiotic therapy and cultures taken during other therapy or antibiotic-free intervals cannot be explained by a nutritional effect of sucrose. However, in general the possibility cannot be excluded that a simple nutritional effect of sucrose may manifest itself in some blood cultures. (ii) Muschel and Larsen (15) demonstrated that sucrose counteracts bactericidal reactions through an anticomplementary effect. All the media used in the present examination, however, contained 0.05% sodium polyanetholesulfonate, which inactivates complement (12).
4 VOL. 16, 1982 ANTIBIOTICS AND GROWTH IN HYPERTONIC BROTH 893 TABLE 3. Antibiotic treatment administered, 3-lactamase production of the strain isolated, and growth patterns in P broth and H broth in 46 clinical blood cultures yielding growth of S. aureus during treatment of the patients with P-lactam antibiotics Patient TreatmentNoofpstv Route of Dosage per Duration of S. aureus blood cultures, with No. Sex Age (yr) Antibiotic (days)2 administration' 1. M 22 Penicillin V P0 6 x106 IU 1-1 P >H, 1H >P 2. M 64 Pivampicillin PO 3. M 75 Penicillin G IV 4. F 76 Penicillin G PE 5. F 64 Penicillin G IV 1.4 g 20 x 106 IU x 106 IU 1 6 x 106 IU Unknown <1-1 P= H,2H >P - 4 P= H,2H>P - 2 H > P - 2 H > P 6. M 17 Ampicillin IV 4 g 1 + 1P=H 7. M 54 Penicillin V PO 3 x 106 IU H > P 8. M 42 Ampicillin IV 9. F 72 Ampicillin IV 10. M 54 Pivampicillin PO 11. M 62 Penicillin G IV Cephalothin IV 4 g 1 + 3P= H 4 g Unknown + 4P= H,2H>P 2.8g 1 30 x 106 IU 1 6 g 1 + 2P= H,1 H>P + 2H > P 12. M 71 Ampicillin Unknown 4 g Unknown + 2 H > P 13. F 47 Methicillin IV 8 g M 14 Penicillin G IV 30 x 106 IU 3 Methicillin IV 4 g F 53 Cephalexin PO 2 g 16. M 49 Penicillin G IV Cephalothin IV 30 x 106 IU 2 6 g 1 + 1H>P + 2P= H,1 H >P 3 + 1H>P + 2H > P 17. M 56 Cloxacillin IV 8 g 3 + 4H > P a PO, Oral; IV, intravenous; PE, parenteral. I Duration of antibiotic treatment before blood cultures were made. I For abbreviations, see Table 1, footnote a. (iii) Simberkoff et al. (17) reported that penicillins are rapidly inactivated by sucrose at alkaline ph. It has been suggested on the basis of this finding that sucrose inactivation of penicillins in samples may permit partially inhibited bacteria to grow only in hypertonic media (13). The sucrose inactivation of penicillins was, however, found to occur at ph above 8, whereas penicillin is quite stable at ph 7.2 to 7.4 (17), which is the ph level of the blood culture media employed in the present study. Moreover, the addition of blood to blood culture media has been found to cause a marked decrease in ph (2). Our media also contained penicillinase in amounts which, according to our measurements, were sufficient to inactivate as much as 400 IU of penicillin G per ml of blood in 2 h at room temperature. The,B-lactam antibiotics most frequently given to our patients were benzylpenicillin, phenoxymethylpenicillin, and ampicillin (Table 3), all of which are sensitive to 3-lactamase derived from B. cereus (1), which was used in our media. For these reasons, we consider it less likely that the enhanced growth promotion of S. aureus in H broth in the cultures collected during P-lactam antibiotic therapy (Table 1) can be explained by the inactivation of penicillins by sucrose. The improved growth in H broth of cultures taken
5 894 ENG AND MAELAND during antibiotic-free intervals (Tables 1 and 2) obviously indicates that other mechanisms must be involved in these cultures. (iv) Sucrose may offer osmotic support to cellwall-defective bacterial forms. Variants of this kind have been produced experimentally with,blactam antibiotics as inducing agents, and, moreover, the formation of spheroplasts through the combined action of serum lysozyme and the complement system has been demonstrated in vitro (14). The latter finding may provide a theoretical explanation of our finding of improvement by sucrose in the growth of S. aureus and Enterobacteriaceae in blood cultures collected in antibiotic-free intervals (Tables 1 and 2). A transitory stage of cell wall defect may be a regular phase in the process of bacterial killing in vivo, whether by P-lactam antibiotics or by lysozyme and other immune substances. Hence, the blood of bacteremic patients may contain, alone or together with classical bacteria, a number of short-lived bacterial cells with various degrees of cell wall defects, and these cells, when trapped in the blood cultures, may be stabilized by the osmotic support of sucrose and be enabled to revert to classical bacteria and subsequently to grow out in the culture. A priori, this phenomenon can be expected to be more pronounced in blood cultures collected when cell-wall-defective forms have been induced by,b-lactam antibiotics in addition to (or possibly in cooperation with) immune induction than it would be in cultures taken in antibioticfree intervals, when immune induction alone is responsible. Our finding of enhanced growth improvement by sucrose of S. aureus in blood cultures collected during P-lactam antibiotic therapy thus harmonizes well with this hypothesis. It is noteworthy that successful isolations of S. aureus in the L form from the blood of patients with chronic staphylococcal infections have earlier been reported (8). It is evident from Tables 1 and 2 that only some cultures displayed growth enhancement by sucrose; most cultures showed simultaneous growth from P broth and H broth. This fact may, in terms of the hypothesis discussed here, be related to differences in the relative numbers of classical bacteria and cell-wall-defective forms in the samples of blood to be cultured. We conclude that the hypothesis that sucrose acts by stabilizing cell-wall-defective bacterial forms fits our findings well. This conclusion does not exclude the possibility that other mechanisms may also be operative in hypertonic blood cultures. J. CLIN. MICROBIOL. ACKNOWLEDGMENTS We gratefully acknowledge the assistance of Ingar Holme of the Life Insurance Companies' Institute for Medical Statistics at the Oslo City Hospitals, who performed the statistical analysis of the data. LITERATURE CITED 1. Abraham, E. P., and S. G. Waley f-lactamases from Bacillus cereus, p In J. M. T. Hamilton- Miller and J. T. Smith (ed.), Beta-lactamases. Academic Press, Inc., London. 2. Beaman, K. D., B. L. Kasten, C. L. Corlett, and T. L. Gavan Effects of blood on blood culture medium. J. Clin. Microbiol. 10: Coleman, R. M., W. W. Laslie, and D. W. Lambe, Jr Clinical comparison of aerobic, hypertonic, and anaerobic culture media for the radiometric detection of bacteremia. J. Clin. Microbiol. 3: Cowan, S. T Cowan and Steel's manual for the identification of medical bacteria, 2nd ed. The Cambridge University Press, London. 5. Difco Laboratories Difco manual, 9th ed., p Difco Laboratories, Detroit, Mich. 6. Ellner, P. D., T. E. Kiehn, J. L. Beebe, and L. R. McCarthy Critical analysis of hypertonic medium and agitation in detection of bacteremia. J. Clin. Microbiol. 4: Eng, J Evaluation of sucrose and magnesium sulfate as additives in aerobic blood culture medium. J. Clin. Microbiol. 14: Godzeski, C. W., G. Brier, R. S. Griffith, and H. R. Black Association of bacterial L-phase organisms in chronic infections. Nature (London) 205: Gross, P. A., R. Fryda, and K. Reilly Comparative evaluation of different types of blood culture media for isolation of aerobes. J. Clin. Microbiol. 6: Henrichsen, J., and B. Bruun An evaluation of the effects of a high concentration of sucrose in blood culture media. Acta Pathol. Microbiol. Scand. Sect. B 81: KJellander, J., and K. E. Myrback A simple test for penicillinase-production. Acta Pathol. Microbiol. Scand. 61: Kocka, F. E., T. Magoc, and R. L. Searcy Action of sulfated polyanions used in blood culture on lysozyme, complement and antibiotics. Ann. Clin. Lab. Sci. 2: McGee, Z. A., R. G. Wittier, H. Gooder, and P. Charache Wall defective microbial variants: terminology and experimental design. J. Infect. Dis. 123: Muschel, L. H The formation of spheroplasts by immune substances and the reactivity of immune substances against diverse rounded forms, p In L. B. Guze (ed.), Microbial protoplasts, spheroplasts and L- forms. The Williams & Wilkins Co., Baltimore. 15. Muschel, L. H., and L. J. Larsen Effect of hypertonic sucrose upon the immune bactericidal reaction. Infect. Immun. 1: Rosner, R A quantitative evaluation of three blood culture systems. Am. J. Clin. Pathol. 57: Simberkoff, M. S., L. Thomas, D. McGregor, I. Shenkein, and B. B. Levine Inactivation of penicillins by carbohydrate solutions at alkaline ph. N. Engl. J. Med. 283: Washington, J. A., H, M. M. Hall, and E. Warren Evaluation of blood culture media supplemented with sucrose or with cysteine. J. Clin. Microbiol. 1:79-81.
Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017
Cell Wall Inhibitors Assistant Professor Naza M. Ali Lec 3 7 Nov 2017 Cell wall The cell wall is a rigid outer layer, it completely surrounds the cytoplasmic membrane, maintaining the shape of the cell
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationNAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H.
46 THE JOURNAL OF ANTIBIOTICS APR. 1976 NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE a G. H. WARREN Research Division, Wyeth Laboratories,
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationRELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING
RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING Pages with reference to book, From 94 To 97 S. Hafiz, N. Lyall, S. Punjwani, Shahida Q. Zaidi ( Department of Microbiology, The Aga Khan University
More informationLactose-Fermenting Bacteria Isolated from Burni Patients
INFECTION AND IMMUNITY, March 1971, p. 411-415 Copyright 1971 American Society for Microbiology Vol. 3, No. 3 Printed in U.S.A. Effect of Antibiotic Treatment on the Incidence of Infectious Drug Resistance
More informationResistance of Coagulase-Positive Staphylococci
JOURNALOF BACrERIOLOGY, Apr., 1965 Copyright a 1965 American Society for Microbiology Vol. 89, No. 4 Printed in U.S.A. Resistance of Coagulase-Positive Staphylococci to Methicillin and Oxacillin CHARLES
More informationEffects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationQuality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck
Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationEvaluation of MicroScan MIC Panels for Detection of
JOURNAL OF CLINICAL MICROBIOLOGY, May 1988, p. 816-820 Vol. 26, No. 5 0095-1137/88/050816-05$02.00/0 Copyright 1988, American Society for Microbiology Evaluation of MicroScan MIC Panels for Detection of
More informationR-factor mediated trimethoprim resistance: result of two three-month clinical surveys
Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationBIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity
BIOLACTAM www.biolactam.eu An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity 1.5-3h 20 Copyright 2014 VL-Diagnostics GmbH. All rights reserved. Product
More informationAntibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi
Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What
More informationMICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,
More informationTherios 300 mg and 750 mg Palatable Tablets for Dogs
Ceva Animal Health Ltd Telephone: 01494 781510 Website: www.ceva.com Email: cevauk@ceva.com Therios 300 mg and 750 mg Palatable Tablets for Dogs Species: Therapeutic indication: Active ingredient: Product:
More informationInternational Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.
I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED
More informationComparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys
ANTIbMCROBIAL AGENTS AND CHEMOTHERAPY, June 197, p. 460-465 Copyright 197 American Society for Microbiology Vol. 1, No. 6 Printed in U.S.A. Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal
More informationSZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science
SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests
More informationEffeet on Bacterial Growth
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 17, p. 36-366 Copyright ( 17 American Society for Microbiology Vol., No. 5 Printed in U.S.A. Automatic Radiometric Measurement of Antibiotic Effeet on Bacterial
More informationTHE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University.
THE STABILITY OF E1VROFLOXA CIN A Senior Thesis By Meagan A. Dodge 1997-98 University Undergraduate Research Fellow Texas ASM University Group: Biology THE STABILITY OF ENROFLOXACIN MEAGANA, DODGE Submitted
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationBurn Infection & Laboratory Diagnosis
Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate
SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.
More informationDrug resistance in relation to use of silver sulphadiazine cream in a burns unit
J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amfipen LA 100 mg/ml suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Each ml contains:
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationavailable. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory
ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae
More informationLactose-Fermenting Bacteria Isolated from
APPuE MICROBIOLOGY, Nov. 969, p. 98-94 VoL 8, No. 5 Copyright 969 American Society for Microbiology Printed in U.S.A. Incidence of Infectious Drug Resistance Among Lactose-Fermenting Bacteria Isolated
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationDemonstration of pathogenic bacteria in "sterile" inflammatory exudates
J Clin Pathol 1983;36:454-458 Demonstration of pathogenic bacteria in "sterile" inflammatory exudates RC BRIDGER From the Department of Microbiology, Godfrey Pathology Laboratory, 137 Kilmore Street, Christchurch
More informationGeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007
GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure
More informationSusceptibility Tests for Methicillin-Resistant (Heteroresistant) Staphylococci
JOURNAL OF CLNCAL MCROBOLOGY, Apr. 1984, p. 482-488 95-1137/84/4482-7$2./ Copyright C) 1984, American Society for Microbiology Vol. 19, No. 4 New Recommendations for Disk Diffusion Antimicrobial Susceptibility
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/389/98-FINAL July 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS ENROFLOXACIN (extension to
More informationTOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya
16 THE JOURNAL OF ANTIBIOTICS JAN. 1972 TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya Biological Research Laboratories, Research
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationUSA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only
USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer
More informationVLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05
Topic J05: Determination of susceptibility of bacteria to antimicrobial drugs, assessments of resistance factors For study: textbooks, www, keywords e. g. Diffusion disc test ; E-test ; dilution micromethod
More informationAntimicrobials. Antimicrobials
Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance
More informationComparison of tablets and paper discs for antibiotic sensitivity testing
J. clin. Path., 1975, 28, 983-988 Comparison of tablets and paper discs for antibiotic sensitivity testing D. F. J. BROWN' AND D. KOTHARI From the Division of Hospital Infection, Clinical Research Centre,
More informationThe Turkish Journal of Pediatrics 2008; 50:
The Turkish Journal of Pediatrics 2008; 50: 120-125 Original Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and
More informationStaphylococcus aureus
J. clin. Path., 197, 23, 19-23 Stability of neomycin resistance in Staphylococcus aureus G. A. J. AYLIFFE From the Hospital Infection Research Laboratory, Summerfield Hospital, Birmingham SYNOPSIS A strain
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationDO NOT WRITE ON or THROW AWAY THIS PAPER!
What Kills Bacteria? Lab Procedure Go to the following link: http://www.glencoe.com/sites/common_assets/science/virtual_labs/ls08/ls08.html or DO NOT WRITE ON or THROW AWAY THIS PAPER! Visit my eboard
More informationDetection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital
ISSN: 2319-7706 Volume 3 Number 9 (2014) pp. 689-694 http://www.ijcmas.com Original Research Article Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a
More informationECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD
Old Herborn University Seminar Monograph 3: Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Editors: Carl Erik Nord, Peter J. Heidt, Volker Rusch, and
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More informationClinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
More informationSusceptibility Testing
APPLIED MICROBIOLOGY, Nov. 1969, p. 766-770 Copyright 1969 American Society for Microbiology Vol. 18, No. 5 Printed in U.S.A. Effect of Mixed Cultures on Antibiotic Susceptibility Testing AZRA SHAHIDI
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE
ANTIMICROBIAL TESTING with ALKA VITA (ALKAHYDROXY ) on ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE FINAL RESULTS OF ANTIBACTERIAL TESTS IN VITRO WITH THE PRODUCT
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationAmoxicillin clavulanic acid spectrum
Cari untuk: Cari Cari Amoxicillin clavulanic acid spectrum 14-8-2017 Amoxicillin and clavulanate potassium (AMC), also known as augmentin, is an antibiotic used to treat bacterial infections. AMC is available
More informationSENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS
Thorax (195), 5, 162. THE BEHAVIOUR OF MIXTURES OF STREPTOMYCIN- SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS BY D. A. MITCHISON* From the Department of Bacteriology, Postgraduate
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationThe Pharmaceutical and Chemical Journal, 2018, 5(1): Research Article
, 2018, 5(1):145-152 Available online www.tpcj.org Research Article ISSN: 2349-7092 CODEN(USA): PCJHBA In Search of the Truth about the Quality of Mueller Hinton Agar and Tested Antimicrobial Discs Daniela
More informationEXCEDE Sterile Suspension
VIAL LABEL MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY EXCEDE Sterile Suspension 200 mg/ml CEFTIOFUR as Ceftiofur Crystalline Free
More information17June2017. Parampal Deol, Ph.D, MBA Senior Director, R&D Microbiology North America
RAPID DETECTION OF BACTERIAL CONTAMINANTS IN PLATELET COMPONENTS: COMPARISON OF TIME TO DETECTION BETWEEN THE BACT/ALERT 3D AND THE BACT/ALERT VIRTUO SYSTEMS. 17June2017 Parampal Deol, Ph.D, MBA Senior
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationTest Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants
Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified
More informationVisit ABLE on the Web at:
This article reprinted from: Lessem, P. B. 2008. The antibiotic resistance phenomenon: Use of minimal inhibitory concentration (MIC) determination for inquiry based experimentation. Pages 357-362, in Tested
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationDynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
More informationApproved by the Food Safety Commission on September 30, 2004
Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food
More informationCell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification
Cell Wall Weakeners Antimicrobials: Drugs that Weaken the Cell Wall Beta Lactams Penicillins Cephalosporins Carbapenems Aztreonam Vancomycin Teicoplanin Bacterial Cell Wall Bacterial cytoplasm is hypertonic
More informationInfluence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (No. 2) REGULATIONS 2007 (S.I. No. 786 of 2007) VPA: 10999/056/001 Case No: 7004318 The Irish Medicines Board in exercise of the powers
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COLICEN 4.000.000 UI/ml solution for use in drinking water/milk 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationPharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE
Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:
More information